Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP

Journal of Molecular Biology

Volumn 269, Issue 4, 1997, Pages 570-578

  Hohenester, Erhard ^a   Hutchinson, Winston L ^b   Pepys, Mark B ^b   Wood, Steve P ^c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Amyloidosis; Drug design; Pentraxin; X ray crystallography

Indexed keywords

ADENINE; CALCIUM ION; DEOXYADENOSINE PHOSPHATE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; SERUM AMYLOID P;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY;

EID: 0031580201     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1075     Document Type: Article

References (41)

1. Baltz M. L., de Beer F. C., Feinstein A., Pepys M. B. Calcium-dependent aggregation of human serum amyloid P component. Biochim. Biophys. Acta. 701:1982;229-236.
2. Brünger A. T. X-PLOR Version 3.1: A System for Crystallography and NMR. 1992a;Yale University Press, New Haven.
3. Brünger A. T. The free R value: a novel statistic quantity for assessing the accuracy of crystal structures. Nature. 355:1992b;472-474.
4. Butler P. J. G., Tennent G. A., Pepys M. B. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Expt. Med. 172:1990;13-18.
5. Collaborative Computing Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
6. de Beer F. C., Baltz M. L., Holford S., Feinstein A., Pepys M. B. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J. Expt. Med. 154:1981;1134-1149.
7. Dickerson R. E. DNA structure from A to Z. Methods Enzymol. 211:1992;67-111.
8. Emsley J., White H. E., O'Hara B. P., Oliva G., Srinivasan N., Tickle I. J., Blundell T. L., Pepys M. B., Wood S. P. Structure of pentameric human serum amyloid P component. Nature. 367:1994;338-345.
9. Engh R. A., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
10. Friedman R. A., Honig B. A free energy analysis of nucleic acid base stacking in aqueous solution. Biophys. J. 69:1995;1528-1535.
11. Gewurz H., Zhang X.-H., Lint T. F. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:1995;54-64.
12. 2+. J. Biol. Chem. 262:1987;1456-1460.
13. Hamazaki H. Calcium-dependent polymerization of human serum amyloid P component is inhibited by heparin and dextran sulfate. Biochim. Biophys. Acta. 998:1989;231-235.
14. Hawkins P. N., Tennent G. A., Woo P., Pepys M. B. Studiesin vivoin vitro. Clin. Exp. Immunol. 84:1991;308-316.
15. Hind C. R. K., Collins P. M., Renn D., Cook R. B., Caspi D., Baltz M. L., Pepys M. B. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J. Expt. Med. 159:1984a;1058-1069.
16. Hind C. R. K., Collins P. M., Caspi D., Baltz M. L., Pepys M. B. Specific dissociation of fibrillar and non-fibrillar components of amyloid deposits. Lancet. ii:1984b;376-378.
17. Jones T. A., Zou J. Y., Cowan S. W., Kjeeldgard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
18. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
19. Leslie A. G. W. MOSFLM Users Guide. 1994;MRC-LMB, Cambridge.
20. Loveless R. W., Floyd-O'Sullivan G., Raynes J. G., Yuen C.-T., Feizi T. Human serum amyloid P component is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose,N. EMBO J. 11:1992;813-819.
21. Matthews B. W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
22. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
23. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;281-296.
24. Norberg J., Nilsson L. Stacking free energy profiles for all 16 natural ribodinucleoside monophosphates in aqueous solution. J. Am. Chem. Soc. 117:1995;10832-10840.
25. Osmand A. P., Friedenson B., Gewurz H., Painter R. H., Hoffman T., Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc. Natl Acad. Sci. USA. 74:1977;739-743.
26. Painter R. H., de Escallon I., Massey A., Pinteric L., Stern S. B. The structure and binding characteristics of serum amyloid protein (9.55 a1-glycoprotein). Ann. N.Y. Acad. Sci. 389:1982;199-213.
27. Pepys M. B. Amyloidosis. Samter's Immunological Disease. 1994;Little, Brown and Company, Boston.
28. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid P component. Advan. Immunol. 34:1983;141-212.
29. Pepys M. B., Butler P. J. G. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148:1987;308-313.
30. Pepys M. B., Dash A. C., Munn E. A., Feinstein A., Skinner M., Cohen A. S., Gewurz H., Osmand A. P., Painter R. H. Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. i:1977;1029-1031.
31. Pepys M. B., Dash A. C., Fletcher T. C., Richardson N., Munn E. A., Feinstein A. Analogues in other mammals and in fish of human plasma proteins C-reactive proteins and amyloid P component. Nature. 273:1978;168-170.
32. Pepys M. B., Rademacher T. W., Amatayakul-Chantler S., Williams P., Noble G. E., Hutchinson W. L., Hawkins P. N., Nelson S. R., Gallimore R. J., Herbert J., Hutton T., Dwek R. A. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl Acad. Sci. USA. 91:1994;5602-5606.
33. Pepys M. B., Tennent G. A., Booth D. R., Bellotti V., Lovat L. B., Tan S. Y., Persey M. R., Hutchinson W. L., Booth S. E., Madhoo S., Soutar A. K., Hawkins P. N., Van Zyl-Smit R., Campistol J. M., Fraser P. E., Radford S. E., Robinson C. V., Sunde M., Serpell L. C., Blake C. C. F. Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapy. The Nature and Origin of Amyloid Fibrils (Ciba Found. Symp. 199). 1996;Wiley, Chichester.
34. Pinteric L., Assimeh S. N., Kells D. I. C., Painter R. H. The ultrastructure of C1t, a subcomponent of the first component of complement: an e.m. and ultracentrifuge study. J. Biol. Chem. 117:1976;79-83.
35. Pontet M., Engler R., Jayle M. F. One-step preparation of both human C-reactive protein and C1t. Fed. Eur. Biol. Soc. Letters. 88:1978;172-178.
36. Rini J. M. Lectin structure. Annu. Rev. Biophys. Biomol. Struct. 24:1995;551-577.
37. Sarma R. H., Dhingra M. M. NMR studies of oligonucleotides in solution. Neidle S. Topics in Nucleic Acid Structure. 1981;Macmillan, London.
38. Saenger W. Principles of Nucleic Acid Structure. 1983;Springer, New York.
39. Schwalbe R. A., Dahlback B., Coe J. E., Nelsestuen G. L. Pentraxin family of proteins interact specifically with phosphocholine and/or phosphorylethanolamine. Biochemistry. 31:1992;4907-4915.
40. Tennent G. A., Lovat L. B., Pepys M. B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc. Natl Acad. Sci. USA. 92:1995;4299-4303.
41. Wood S. P., Oliva G., O'Hara B. P., White H. E., Blundell T. L., Perkins S. J., Sardharwalla I., Pepys M. B. A pentameric form of human serum amyloid P component. Crystallization, X-ray diffraction and neutron scattering studies. J. Mol. Biol. 202:1988;169-173.